Literature DB >> 12789103

Spectrophotometric determination of sulphamethoxazole and trimethoprim (co-trimoxazole) in binary mixtures and in tablets.

S Balyejjusa1, R O Adome, D Musoke.   

Abstract

BACKGROUND: The formulation of sulphamethoxazole (S) and trimethoprin (T) (CO-TRIMOXAZOLE) in a combination mixture is very good pharmacologically since it enhances the efficacy of the individual drugs. However in this combination, difficulties in analysis on ordinary UV spectrophotometry are introduced because the two components give overlapping spectral bands on zero-order. The United States Pharmacopoea (USP)-recommended HPLC analytical method is quite expensive.
OBJECTIVE: The objective of the present work was to assess whether derivative spectrophotometry could be used to circumvent the overlapping spectral bands of the components and hence use it for routine analysis of the drug. STUDY
DESIGN: Experimental.
METHODS: The aqueous solution of the individual drugs and their binary mixtures were scanned on zero order and on first derivative at the wave length between 200- 300 nm and at the pH of 4.5.
RESULTS: The zero-order spectra of the compounds were completely overlapping. However the first-derivative scan offered better separation and hence T was determined from the absorbance at 237.6 nm with negligible contribution from S (since at this point it was reading zero). Likewise S was determined at a wavelength of 259 nm when T was reading zero. The linear calibration graphs were obtained for 4-25 microg x ml(-1) of S and for 4-20 microg x ml(-1) of T.
CONCLUSION: The method is rapid, simple and can be applied successfully to assay a mixture of the two drugs in pharmaceutical preparations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12789103      PMCID: PMC2141573     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  7 in total

1.  Determination of active ingredients in the pharmaceutical formulations containing hydrochlorothiazide and its binary mixtures with benazepril hydrochloride, triamterene and cilazapril by ratio spectra derivative spectrophotometry and vierordt's method.

Authors:  N Erk
Journal:  J Pharm Biomed Anal       Date:  1999-06       Impact factor: 3.935

2.  Simultaneous determination of sulphathiazole and sulphanilamide in pharmaceuticals by derivative spectrophotometry.

Authors:  J J Berzas Nevado; F Salinas; I de Orbe Paya; L F Capitan-Vallvey
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

3.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

4.  Simultaneous determination of paracetamol and methocarbamol in tablets by ratio spectra derivative spectrophotometry and LC.

Authors:  N Erk; Y Ozkan; E Banoğlu; S A Ozkan; Z Sentürk
Journal:  J Pharm Biomed Anal       Date:  2001-01       Impact factor: 3.935

5.  Simultaneous determination of flavor enhancers inosine 5'-monophosphate and guanosine 5'-monophosphate in food preparations by derivative spectrophotometry.

Authors:  I Durán-Merás; F Salinas; A Muñoz De La Peña; M López Rosas
Journal:  J AOAC Int       Date:  1993 Jul-Aug       Impact factor: 1.913

6.  Analysis of sulfamethazine in the presence of sulfamerazine or sulfadiazine by first-derivative photochemically induced fluorescence.

Authors:  M Sanchez Pena; M J Acedo; F Salinas; M C Mahedero; J J Aaron
Journal:  J Pharm Biomed Anal       Date:  1995-08       Impact factor: 3.935

7.  Simultaneous determination of acetylsalicylic and salicylic acids in human serum and aspirin formulations by second-derivative synchronous fluorescence spectrometry.

Authors:  D G Konstantianos; P C Ioannou; C E Efstathiou
Journal:  Analyst       Date:  1991-04       Impact factor: 4.616

  7 in total
  1 in total

1.  The optimum pH for the derivative spectrophotometric determination of co-trimoxazole in binary mixtures.

Authors:  R O Adome; S Balyejjusa
Journal:  Afr Health Sci       Date:  2002-12       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.